These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1219667)

  • 1. A study of the energy and biochemical status of obese and non-obese students treated with 780SE.
    Miller DS; Evans E; Samuel P; Burland WL
    Postgrad Med J; 1975; 51 Suppl 1():117-20. PubMed ID: 1219667
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological effects of 780SE (992) on hyperlipidaemic and obese rats.
    Duhault J; Boulander M; Beregi L
    Postgrad Med J; 1975; 51 Suppl 1():99-104. PubMed ID: 1219688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts.
    Tomlinson SA; Lines JG; Greenfield MA
    Postgrad Med J; 1975; 51 Suppl 1(593):166-70. PubMed ID: 768962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fenfluramine and 780SE on fat absorption.
    Evans E; Miller DS; Samuel PD; Burland WL
    Postgrad Med J; 1975; 51 Suppl 1():115-6. PubMed ID: 1219665
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral and metabolic effects of fenfluramine, 780SE, norfenfluramine and hydroxyethylnorfenfluramine--a review.
    Macrae SM
    Postgrad Med J; 1975; 51 Suppl 1():13-7. PubMed ID: 768953
    [No Abstract]   [Full Text] [Related]  

  • 7. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronotherapy of obesity. I. Effect of fenfluramine on the decrease of adipose mass in the obese, in relation to the time of administration].
    Guagnano MT; Di Vincenzo M; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(12):736-9. PubMed ID: 7104096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of the thermic effect of food by d-fenfluramine.
    Levitsky DA; Stallone D
    Clin Neuropharmacol; 1988; 11 Suppl 1():S90-2. PubMed ID: 3180111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 780SE in the management of disorders of lipid and glucose metabolism.
    Riveline B
    Postgrad Med J; 1975; 51 Suppl 1():162-4. PubMed ID: 1219674
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of benfluorex in obese patients with metabolic disorders.
    di Martino G; Federico P; Mattera E; Jacono G
    Br J Clin Pract; 1989 Jun; 43(6):201-8. PubMed ID: 2597599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fenfluramine on the metabolism of calcium and phosphorus in the rat: fenfluramine effects on Ca and P metabolism.
    Ifon ET; Ebong PE; Palaniappan KG; Umoh IB; Eka OU
    Cent Afr J Med; 1992 Mar; 38(3):100-8. PubMed ID: 1516116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
    Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
    Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the effects of 780SE on carbohydrate tolerance and plasma hormone and lipid profile in maturity-onset diabetes.
    Asmal AC; Leary WP
    Postgrad Med J; 1975; 51 Suppl 1(593):144-8. PubMed ID: 768955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects.
    Balasse EO; Couturier E; Kornitzer M; Degre S
    Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration].
    Di Vincenzo M; Guagnano MT; Della Loggia F; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(12):740-4. PubMed ID: 7104097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.